Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients
- 1 August 2018
- journal article
- research article
- Published by Elsevier in European Urology Oncology
- Vol. 1 (3) , 231-237
Abstract
No abstract availableKeywords
Funding Information
- Amgen Nederland
- Astellas Pharma
This publication has 20 references indexed in Scilit:
- Population Based Study of Predictors of Adverse Pathology among Candidates for Active Surveillance with Gleason 6 Prostate CancerJournal of Urology, 2014
- Expanded Criteria to Identify Men Eligible for Active Surveillance of Low Risk Prostate Cancer at Johns Hopkins: A Preliminary AnalysisJournal of Urology, 2013
- Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS StudyEuropean Urology, 2013
- Outcomes of initially expectantly managed patients with low or intermediate risk screen‐detected localized prostate cancerBJU International, 2012
- Active Surveillance for Prostate Cancer: Progress and PromiseJournal of Clinical Oncology, 2011
- Risk Stratification and Validation of Prostate Specific Antigen Density as Independent Predictor of Progression in Men With Low Risk Prostate Cancer During Active SurveillanceJournal of Urology, 2011
- Risk Stratification of Men Choosing Surveillance for Low Risk Prostate CancerJournal of Urology, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Prospective Validation of Active Surveillance in Prostate Cancer: The PRIAS StudyEuropean Urology, 2007
- Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical OutcomesJournal of Urology, 2007